Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 22, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-report
Related Tickers: RDY
TL;DR
RDY files 6-K, standard foreign issuer report, no new info.
AI Summary
Dr. Reddy's Laboratories Limited, based in Hyderabad, India, filed a Form 6-K on September 22, 2025. This report is a routine filing for a foreign private issuer and indicates the company files its annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its classification as a report of a foreign private issuer.
Why It Matters
This filing confirms Dr. Reddy's Laboratories' status as a foreign private issuer and its adherence to SEC reporting requirements for such entities.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material non-public information that would typically impact stock price.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-25-000587 (filing_id) — Accession Number
- 20250922 (date) — Filing Date
- 1-15182 (sec_file_number) — SEC File Number
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
Who is the filer of this report?
The filer is Dr. Reddy's Laboratories Limited.
When was this report filed?
This report was filed on September 22, 2025.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for Dr. Reddy's Laboratories?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Filing Stats: 399 words · 2 min read · ~1 pages · Grade level 16.5 · Accepted 2025-09-22 09:39:49
Filing Documents
- rdy0806_6k.htm (6-K) — 49KB
- rdy0806_ex99-1.htm (EX-99.1) — 21KB
- rdy0806_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0806_ex99-1img02.jpg (GRAPHIC) — 6KB
- 0001575872-25-000587.txt ( ) — 94KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: September 22, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3